Get the app
USHealthcare

agilon health Inc (AGL)

US · Healthcare · Medical Care Facilities

$89.17-0.55%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$1.49B
Revenue YoY
+7.2%
Net profit
$18.0M
EPS
$1.04
EPS estimate
$0.06
Net margin
1.2%

EPS came in at 1.04 against a street estimate of 0.06 — a beat of 1633.3%.

Key statistics

Market cap
$1.51B
Forward P/E
178.6
P/B
6.62
Book value
$13.55
EPS (TTM)
$-15.23
52-week high
$133.04
52-week low
$7.48
50-day MA
$100.28
200-day MA
$53.09
Beta
3.04

Analyst view

Analysts rate agilon health Inc a hold (4 buy, 14 hold, 2 sell out of 20) with an average price target of $115.08.

Shareholding

Insiders
5.04%
Institutions
96.47%

Largest institutional holders

FundStake
Clayton Dubilier & Rice LLC23.82%
North Peak Capital Management, LLC8.84%
Durable Capital Partners LP2.62%
D. E. Shaw & Co LP2.32%
Rock Springs Capital Management LP1.56%
Two Sigma Investments LLC0.75%
Morgan Stanley - Brokerage Accounts0.50%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC0.43%

Recent filings & reports

DocumentDate
Quarterly report · Q2 2026
AGILON HEALTH, INC. – FORM 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Net income (6M 2026): $66.9 million vs. net loss of $92.3 million (6M 2025) — m
2026-08-05
Results announced · Q3 2026
AGILON HEALTH Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Total revenues: $1.49 billion in Q2 2026, up 7% from $1.39 billion in Q2 2025 • Net income:
2026-08-05
Board / officer change · Q3 2026
AGILON HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Cash severance payment to departing CTO: $766,063.00 (paid in installments over 12 months
2026-07-22
Shareholder vote results · Q2 2026
AGILON HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held June 2, 2026 • Company trades on NYSE under ticker symbol
2026-06-03
Quarterly report · Q1 2026
AGILON HEALTH, INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenues (Q1 2026): $1,420.5 million (down from $1,532.8 million in Q1 2025; -7.
2026-05-06
Results announced · Q2 2026
AGILON HEALTH Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total Revenue: $1,420 million in Q1 2026, down 7% from $1,533 million in Q1 2025 • Net Inc
2026-05-06
Proxy statement · Q2 2026
AGILON HEALTH, INC. — 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of three Class II directors for three-year
2026-04-22
Annual report FY2025
AGILON HEALTH, INC. - FORM 10-K SUMMARY HEADLINE NUMBERS • Company formed in 2016; established first anchor physician group partnership in 2017 • As
2026-02-25

Readable in the app.

Corporate actions

ActionDetailDate
Split1 : 25
effective Mar 31, 2026
2026-03-31

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for agilon health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.